BioLargo, Inc. (BLGO)
OTCMKTS · Delayed Price · Currency is USD
0.1200
-0.0100 (-7.69%)
May 18, 2026, 3:54 PM EST
BioLargo Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5.61 | 7.77 | 17.78 | 12.23 | 5.88 | 2.53 | |
Revenue Growth (YoY) | -65.55% | -56.33% | 45.37% | 107.85% | 132.48% | 4.07% |
Cost of Revenue | 3.24 | 4.36 | 9.93 | 6.08 | 3.03 | 1.43 |
Gross Profit | 2.38 | 3.41 | 7.85 | 6.15 | 2.86 | 1.1 |
Selling, General & Admin | 12 | 11.77 | 9.3 | 8.06 | 6.73 | 6.17 |
Research & Development | 2.71 | 2.59 | 2.88 | 2.28 | 1.32 | 1.37 |
Other Operating Expenses | - | - | - | 0.01 | -0.06 | -0.02 |
Operating Expenses | 18.56 | 18.25 | 12.18 | 10.35 | 7.99 | 7.52 |
Operating Income | -16.18 | -14.84 | -4.33 | -4.2 | -5.13 | -6.42 |
Interest Expense | -0.64 | -0.54 | -0.07 | -0.09 | -0.05 | -0.23 |
Interest & Investment Income | 0.24 | 0.2 | 0.04 | - | - | - |
Other Non Operating Income (Expenses) | -0.09 | 0.01 | -0.08 | 0.04 | 0.07 | 0.06 |
EBT Excluding Unusual Items | -16.66 | -15.18 | -4.44 | -4.25 | -5.11 | -6.6 |
Asset Writedown | -0.01 | -0.01 | - | -0.39 | -0.2 | -0.34 |
Other Unusual Items | - | - | 0.1 | - | 0.17 | 0.04 |
Pretax Income | -16.67 | -15.19 | -4.35 | -4.65 | -5.13 | -6.89 |
Earnings From Continuing Operations | -16.67 | -15.19 | -4.35 | -4.65 | -5.13 | -6.89 |
Minority Interest in Earnings | 3.76 | 3.41 | 1.95 | 1.14 | 0.66 | -0.19 |
Net Income | -12.91 | -11.78 | -2.4 | -3.5 | -4.47 | -7.08 |
Net Income to Common | -12.91 | -11.78 | -2.4 | -3.5 | -4.47 | -7.08 |
Shares Outstanding (Basic) | 311 | 307 | 298 | 286 | 268 | 247 |
Shares Outstanding (Diluted) | 311 | 307 | 298 | 286 | 268 | 247 |
Shares Change (YoY) | 3.82% | 2.96% | 4.25% | 6.58% | 8.54% | 26.13% |
EPS (Basic) | -0.04 | -0.04 | -0.01 | -0.01 | -0.02 | -0.03 |
EPS (Diluted) | -0.04 | -0.04 | -0.01 | -0.01 | -0.02 | -0.03 |
Free Cash Flow | -9.46 | -8.34 | -4.44 | -2.84 | -3.03 | -3.96 |
Free Cash Flow Per Share | -0.03 | -0.03 | -0.01 | -0.01 | -0.01 | -0.02 |
Gross Margin | 42.34% | 43.86% | 44.17% | 50.32% | 48.55% | 43.58% |
Operating Margin | -288.42% | -191.13% | -24.36% | -34.33% | -87.19% | -253.50% |
Profit Margin | -230.10% | -151.71% | -13.51% | -28.65% | -76.02% | -279.73% |
Free Cash Flow Margin | -168.63% | -107.44% | -24.98% | -23.25% | -51.55% | -156.38% |
EBITDA | -16.05 | -14.7 | -4.18 | -4.1 | -5.09 | -6.4 |
EBITDA Margin | -285.97% | -189.26% | -23.49% | -33.49% | -86.42% | -252.71% |
D&A For EBITDA | 0.14 | 0.15 | 0.16 | 0.1 | 0.05 | 0.02 |
EBIT | -16.18 | -14.84 | -4.33 | -4.2 | -5.13 | -6.42 |
EBIT Margin | -288.42% | -191.13% | -24.36% | -34.33% | -87.19% | -253.50% |
Revenue as Reported | 5.61 | 7.77 | 17.78 | 12.23 | 5.88 | 2.53 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.